Rhythm Pharmaceuticals, Inc. RYTM Deferred income
Deferred income at other companies
Other financials
Where this comes from
Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredRevenueCurrent.
The official record: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rhythm Pharmaceuticals, Inc.'s deferred income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rhythm Pharmaceuticals, Inc.'s deferred income?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported deferred income of $48K in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s deferred income changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s deferred income decreased by 96.3% year-over-year, from $1.3M to $48K.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s deferred income?
- Over 4 years (2021 to 2025), Rhythm Pharmaceuticals, Inc.'s deferred income has grown at a -59.2% compound annual growth rate (CAGR), from $7M to $194K.